Journals

Human Cloning, Morality, and the US Government (Part 1) logo in a gray background |
Cell Therapies
Human Cloning, Morality, and the US Government (Part 1)Human Cloning, Morality, and the US Government (Part 1)
byBPI Contributor
Mar 1, 2003
Let the Supplier Administer Independent Third-Party Inspections logo in a gray background |
Supply Chain
Let the Supplier Administer Independent Third-Party InspectionsLet the Supplier Administer Independent Third-Party Inspections
byBPI Contributor
Mar 1, 2003

All Journals

Managing Intellectual Property in Alliances logo in a gray background | Managing Intellectual Property in Alliances
Intellectual Property
Managing Intellectual Property in Alliances
Managing Intellectual Property in Alliances
Mar 1, 2003
byBPI Contributor
One World, One Industry — Many Voices logo in a gray background | One World, One Industry — Many Voices
Business
One World, One Industry — Many Voices
One World, One Industry — Many Voices
Mar 1, 2003
byBPI Contributor
Conferences, Courses, and Events logo in a gray background | Conferences, Courses, and Events
Business
Conferences, Courses, and Events February 2003
Conferences, Courses, and Events February 2003
Feb 1, 2003
byBPI Contributor
Products, Services, and Literature logo in a gray background | Products, Services, and Literature
Business
Products, Services, and Literature February 2003
Products, Services, and Literature February 2003
Feb 1, 2003
byBPI Contributor
Big Pharma Talks Back logo in a gray background | Big Pharma Talks Back
Economics
Big Pharma Talks Back
Big Pharma Talks Back
Feb 1, 2003
byBPI Contributor
Glossary of International Biotherapeutic Regulation logo in a gray background | Glossary of International Biotherapeutic Regulation
Regulatory Affairs
Glossary of International Biotherapeutic Regulation
Glossary of International Biotherapeutic Regulation
Feb 1, 2003
byBPI Contributor
Quantity In, Quality Out logo in a gray background | Quantity In, Quality Out
Economics
Quantity In, Quality Out
Quantity In, Quality Out
Feb 1, 2003
byBPI Contributor
So What Are GMPs, Anyway? logo in a gray background | So What Are GMPs, Anyway?
Regulatory Affairs
So What Are GMPs, Anyway?
So What Are GMPs, Anyway?
Feb 1, 2003
byBPI Contributor
Web Services Architecture logo in a gray background | Web Services Architecture
Information Technology
Web Services Architecture
Web Services Architecture
Feb 1, 2003
byBPI Contributor
Structural Signatures for Analysis and Characterization of Biological Products logo in a gray background | Structural Signatures for Analysis and Characterization of Biological Products
Product Characterization
Structural Signatures for Analysis and Characterization of Biological Products
Structural Signatures for Analysis and Characterization of Biological Products
Feb 1, 2003
byBPI Contributor
The Case for Serum-Free Media logo in a gray background | The Case for Serum-Free Media
Cell Culture Media
The Case for Serum-Free Media
The Case for Serum-Free Media
Feb 1, 2003
byBPI Contributor
Three Activity-Based Assays for Serp-1 logo in a gray background | Three Activity-Based Assays for Serp-1
Assays
Three Activity-Based Assays for Serp-1
Three Activity-Based Assays for Serp-1
Feb 1, 2003
byBPI Contributor
Products, Services, and Literature logo in a gray background | Products, Services, and Literature
Business
Products, Services, and Literature January 2003
Products, Services, and Literature January 2003
Jan 1, 2003
byBPI Contributor
Establishing Resin Lifetime logo in a gray background | Establishing Resin Lifetime
Chromatography
Establishing Resin Lifetime
Establishing Resin Lifetime
Jan 1, 2003
byBPI Contributor
Validation of Virus Filtration logo in a gray background | Validation of Virus Filtration
Bioanalytical Methods
Validation of Virus Filtration
Validation of Virus Filtration
Jan 1, 2003
byBPI Contributor
BVD Virus logo in a gray background | BVD Virus
Business
BVD Virus
BVD Virus
Jan 1, 2003
byBPI Contributor
Conferences, Courses, and Events logo in a gray background | Conferences, Courses, and Events
Business
Conferences, Courses, and Events January 2003
Conferences, Courses, and Events January 2003
Jan 1, 2003
byBPI Contributor
From the Publisher and the Editors logo in a gray background | From the Publisher and the Editors
Business
From the Publisher and the Editors
From the Publisher and the Editors
Jan 1, 2003
byBPI Contributor
Growing Pains logo in a gray background | Growing Pains
Facility Design/Engineering
Growing Pains
Growing Pains
Jan 1, 2003
byBPI Contributor
Monitoring "Live" Cell Concentrations in Real Time logo in a gray background | Monitoring "Live" Cell Concentrations in Real Time
Microbial Cell Culture
Monitoring "Live" Cell Concentrations in Real Time
Monitoring "Live" Cell Concentrations in Real Time
Jan 1, 2003
byBPI Contributor
Of SNPS, TRIPS, and Human Dignity logo in a gray background | Of SNPS, TRIPS, and Human Dignity
Intellectual Property
Of SNPS, TRIPS, and Human Dignity
Of SNPS, TRIPS, and Human Dignity
Jan 1, 2003
byBPI Contributor
Opportunities and Needs for the US Biotechnology Industry logo in a gray background | Opportunities and Needs for the US Biotechnology Industry
Economics
Opportunities and Needs for the US Biotechnology Industry
Opportunities and Needs for the US Biotechnology Industry
Jan 1, 2003
byBPI Contributor
Problems Facing Start-Ups logo in a gray background | Problems Facing Start-Ups
Economics
Problems Facing Start-Ups
Problems Facing Start-Ups
Jan 1, 2003
byBPI Contributor
Substantially Improved Stability of Biological Agents in Dried Form logo in a gray background | Substantially Improved Stability of Biological Agents in Dried Form
Fill/Finish
Substantially Improved Stability of Biological Agents in Dried Form
Substantially Improved Stability of Biological Agents in Dried Form
Jan 1, 2003
byBPI Contributor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024